What does this research mean for the field?

Benzimidazole derivative Compound 8d is a potent dual inhibitor of EGFR and BRAF V600E that induces apoptosis and exhibits high gastrointestinal absorption. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to evaluate the effectiveness of benzimidazole derivatives as inhibitors of EGFR and BRAF V600E.

May 16, 2026Open Access

Benzimidazole derivatives as dual EGFR and BRAF V600E inhibitors with pro-apoptotic antiproliferative potential

Key Points

The study aims to evaluate the effectiveness of benzimidazole derivatives as inhibitors of EGFR and BRAF V600E.
Assessment of compound 8d's inhibitory activity against EGFR and BRAF V600E.
Evaluation of pro-apoptotic effects and antiproliferative potential.
Analysis of gastrointestinal absorption characteristics.
Compound 8d demonstrated potent dual inhibitory activity against EGFR and BRAF V600E.
Induction of apoptosis was confirmed as a significant effect.
Compound showed high gastrointestinal absorption properties.

Abstract

Compound 8d exhibited potent dual inhibitory activity against EGFR and BRAF V600E . It induces apoptosis, with high gastrointestinal absorption.

Bookmark

View Full Paper

Bookmark

View Full Paper

Benzimidazole derivatives as dual EGFR and BRAF V600E inhibitors with pro-apoptotic antiproliferative potential

Key Points

Abstract

Cite This Study